Fierce Healthcare December 12, 2019
CVS is launching a new oncology care program.
CVS is launching a new program aimed at boosting access to genetic testing for people with advanced cancers.
Through the Transform Oncology Care program, CVS is partnering with precision medicine company Tempus to make it easier for oncologists to offer advanced genomic tests to patients.
These broad panel tests identify more individual variations in cancer that allow docs to pinpoint the best treatment option.
Tempus’ platform also allows for rapid enrollment in clinical trials for eligible patients, CVS officials said.
The program will be available nationwide to health plans who contract with CVS Caremark, with Aetna launching it for participating provider networks in fully insured commercial plans across 12...
Today's Sponsors
Today's Sponsor